Εμφανίζονται 1 - 15 Αποτελέσματα από 15 για την αναζήτηση '"ПЕРФУЗИОННАЯ СЦИНТИГРАФИЯ МИОКАРДА"', χρόνος αναζήτησης: 0,57δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συνεισφορές: the study was supported by Russian Science Foundation grant No. 23-75- 01085, https://rscf.ru/project/23-75-01085/ ., исследование выполнено за счет гранта Российского научного фонда № 23-75-01085, https://rscf.ru/project/23-75-01085/.

    Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 39, № 2 (2024); 149-159 ; Сибирский журнал клинической и экспериментальной медицины; Том 39, № 2 (2024); 149-159 ; 2713-265X ; 2713-2927

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/2233/954; Kunadian V., Chieffo A., Camici P.G., Berry C., Escaned J., Maas A.H.EM. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur. Heart J. 2020;41(37):3504–3520. DOI:10.1093/eurheartj/ehaa503.; Рябов В.В., Федорова С.Б., Вышлов Е.В. Инфаркт миокарда без обструктивного коронарного атеросклероза – актуальная проблема неотложной кардиологии. Сибирский журнал клинической и экспериментальной медицины. 2018;33(4):10–18. DOI:10.29001/2073-8552-2018-33-4-10-18.; Утегенов Р.Б., Бессонов И.С. Особенности диагностики и лечения ишемической болезни сердца у пациентов без обструктивного атеросклеротического поражения коронарных артерий. Сибирский журнал клинической и экспериментальной медицины. 2023;38(2):30–37. DOI:10.29001/2073-8552-2023-38-2-30-37.; Sun R., Ma R., Wang M., Han K., Zhang Z., Wang L. et al. Prognostic value of myocardial flow reserve derived by quantitative SPECT for patients with intermediate coronary stenoses. J. Nucl. Cardiol. 2023;30(4):1427–1436. DOI:10.1007/s12350-022-03186-z.; Li L., Pang Z., Wang J., Chen Y., Chu H., He Z. et al. Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA. J. Nucl. Cardiol. 2023;30(6):2578–2592. DOI:10.1007/s12350-023-03332-1.; Завадовский К.В., Веснина Ж.В., Анашбаев Ж.Ж., Мочула А.В., Сазонова С.И., Ильюшенкова Ю.Н. и др. Современное состояние ядерной кардиологии в Российской Федерации. Российский кардиологический журнал. 2022;27(12):5134. DOI:10.15829/1560-4071-2022-5134.; Nakajima K., Okuda K., Matsuo S., Slomka P. Making the invisible visible: Phase dyssynchrony has potential as a new prognostic marker. J. Nucl. Cardiol. 2019;26(1):298–302. DOI:10.1007/s12350-017-0929-5.; Chen J., Garcia E.V., Folks R.D., Cooke C.D., Faber T.L., Tauxe E.L. et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J. Nucl. Cardiol. 2005;12(6):687–695. DOI:10.1016/j.nuclcard.2005.06.088.; Aggarwal H., AlJaroudi W.A., Mehta S., Mannon R., Heo J., Iskandrian A.E. et al. The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease. J. Nucl. Cardiol. 2014;21(4):739–746. DOI:10.1007/s12350-014-9886-4.; Pazhenkottil A.P., Buechel R.R., Husmann L., Nkoulou R.N., Wolfrum M., Ghadri J.R. et al. Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging. Heart. 2011;97(1):33–37. DOI:10.1136/hrt.2010.201566.; Hess P.L., Shaw L.K., Fudim M., Iskandrian A.E., Borges-Neto S. The prognostic value of mechanical left ventricular dyssynchrony defined by phase analysis from gated single-photon emission computed tomography myocardial perfusion imaging among patients with coronary heart disease. J. Nucl. Cardiol. 2017;24(2):482–490. DOI:10.1007/s12350-015-0388-9.; Zhang F., Yang W., Wang Y., Tang H., Wang J., Shao X. et al. Is there an association between hibernating myocardium and left ventricular mechanical dyssynchrony in patients with myocardial infarction? Hell. J. Nucl. Med. 2018;21(1):28–34. DOI:10.1967/s002449910704.; Henzlova M.J., Duvall W.L., Einstein A.J., Travin M.I., Verberne H.J. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. [Published correction appears in J. Nucl. Cardiol. 2016;23(3):640–642]. J. Nucl. Cardiol. 2016;23(3):606–639. DOI:10.1007/s12350-015-0387-x.; Heusch G. Myocardial stunning and hibernation revisited. Nat. Rev. Cardiol. 2021;18(7):522–536. DOI:10.1038/s41569-021-00506-7.; Cortés C.M., Aramayo G. E.N., Barboza P.E., Crottogini A., Embon M.A. Impact of early post-stress 99mTc sestamibi ECG-gated SPECT myocardial perfusion imaging on the detection of ischemic LV dyssynchrony: an early step in the stunning cascade. Int. J. Cardiovasc. Imaging. 2021;37(5):1789–1798. DOI:10.1007/s10554-020-02145-4.; Otaki Y., Fish M.B., Miller R.J.H., Lemley M., Slomka P.J. Prognostic value of early left ventricular ejection fraction reserve during regadenoson stress solid-state SPECT-MPI. J. Nucl. Cardiol. 2022;29(3):1219–1230. DOI:10.1007/s12350-020-02420-w.; Askew J.W., Miller T.D., Ruter R.L., Jordan L.G., Hodge D.O., Gibbons R.J. et al. Early image acquisition using a solid-state cardiac camera for fast myocardial perfusion imaging. J. Nucl. Cardiol. 2011;18(5):840–846. DOI:10.1007/s12350-011-9423-7.; Al Jaroudi W., Alraies M.C., DiFilippo F., Brunken R.C., Cerqueira M.D., Jaber W.A. Effect of stress testing on left ventricular mechanical synchrony by phase analysis of gated positron emission tomography in patients with normal myocardial perfusion. Eur. J. Nucl. Med. Mol. Imaging. 2012;39:665–672. DOI:10.1007/s00259-011-2025-4.; Van Tosh A., Votaw J.R., Cooke C.D., Reichek N., Palestro C.J., Nichols K.J. Relationships between left ventricular asynchrony and myocardial blood flow. J. Nucl. Cardiol. 2017;24(1):43–52. DOI:10.1007/s12350-015-0270-9.; Van Tosh A., Votaw J.R., David Cooke C., Cao J.J., Palestro C.J., Nichols K.J. Relationship of 82Rb PET territorial myocardial asynchrony to arterial stenosis. J. Nucl. Cardiol. 2020;27(2):575–588. DOI:10.1007/s12350-018-1350-4.; https://www.sibjcem.ru/jour/article/view/2233

  2. 2
  3. 3
    Academic Journal

    Συνεισφορές: РФФИ в рамках научного проекта № 18-315-00106

    Πηγή: Siberian Journal of Clinical and Experimental Medicine; Том 33, № 2 (2018); 35-41 ; Сибирский журнал клинической и экспериментальной медицины; Том 33, № 2 (2018); 35-41 ; 2713-265X ; 2713-2927 ; 10.29001/2073-8552-2018-33-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/449/365; Bohm M., La Rosee K., Schwinger R. H., Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J. Am. Coll. Cardiol. 1995; 25: 146–153.; Patel A. D., Iskandrian A. E. MIBG imaging. J. Nucl. Cardiol. 2002; 9: 75–94.; Merlet P., Pouillart F., Dubois-Rande J. L., Delahaye N., Fumey R., Castaigne A, Syrota A. Sympathetic nerve alterations assessed with 123IMIBG in the failing human heart. J. Nucl. Med. 1999; 40: 224–231.; Bombardieri E., Giammarile F., Aktolun C., Baum R. P., Bischof Delaloye A., Maffioli L. 131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur. J. Nucl. Med. Mol. Imaging. 2010; 37 (12): 2436–2446.; Al Badarin F., Wimmer A. P., Kennedy K. F., Jacobson A. F., Bateman T. M. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: Incremental prognostic benefit of cardiac 123I-mIBG scintigraphy. J. Nucl. Cardiol. 2014; 21(4): 756–762.; Piña I. L., Carson P., Lindenfeld J. A., Archambault W. T., Jacobson A. F. Persistence of 123I-mIBG Prognostic Capability in Relation to Medical Therapy in Heart Failure (from the ADMIRE-HF Trial). Am. J. Cardiol. 2017; 119(3): 434–439.; Jacobson A. F., Senior R., Cerqueira M. D., Wong N. D., Thomas G. S., Lopez V. A., Agostini D., Weiland F., Chandna H., Narula J. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J. Am. Coll. Cardiol. 2010; 55: 2212–2221.; Flotats A., Carrió I., Agostini D., Le Guludec D., Marcassa C., Schäfers M., Somsen G. A., Unlu M., Verberne H. J. European Council of Nuclear Cardiology. Proposal for standardization of 123 I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur. J. Nucl. Med. Mol. Imaging. 2010; 37 (9): 1802–1812.; Завадовский К. В., Мишкина А. И., Мочула А. В., Лишманов Ю. Б. Методика устранения артефактов движения сердца при выполнении перфузионной сцинтиграфии миокарда. Российский электронный журнал лучевой диагностики. 2017; 7(2): 56–64. DOI:10.21569/2222-7415-2017-7-2-56-64.; Gimelli A., Liga R., Giorgetti A., Genovesi D., Marzullo P. Assessment of myocardial adrenergic innervation with a solidstate dedicated cardiac cadmium zinc telluride camera: first clinical experience. Eur. Heart J. Cardiovasc. Imaging. 2014; 15: 575–585.; Bellevre D., Manrique A., Legallois D., Bross S., Baavour R., Roth N., Blaire T., Desmonts C., Bailliez A., Agostini D. First determination of the heart-to-mediastinum ratio using cardiac dual isotope (123I-MIBG/99mTc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study. Eur. J. Nucl. Med. Mol. Imaging. 2015; 42: 1912–1919.; Clements I. P., Garcia E. V., Chen J., Folks R. D., Butler J., Jacobson A. F. Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT. J. Nucl. Cardiol. 2016; 23(3): 425– 435. DOI:10.1007/s12350-015-0097-4.; Clements I. P., Kelkar A. A., Garcia E. V., Butler J., Chen J., Folks R., Jacobson A. F. Prognostic significance of 123I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure. Eur. Heart J. Cardiovasc. Imaging. 2016; 17(4): 384–390. DOI:10.1093/ehjci/jev295.; Sata N., Kawano T., Hamada N., Horinouchi T., Amitani S., Moriyama Y., Miyahara K. Predictor of underlying myocardial damage in normally functioning left ventricle with narrow QRS complex: relationship between QRS duration at right ventricle pacing and iodine-123 metaiodobenzylguanidine myocardial scintigraphy. Ann. Nucl. Medicine. 2009; 23(7): 639–641. DOI:10.1007/s12149-009-0285-x.; Brieke A., De Nofrio D. Right ventricular dysfunction in chronic dilated cardiomyopathy and heart failure. Coronary Artery Disease. 2005; 16(1): 5–11.; Tabereaux P. B., Doppalapudi H., Kay G. N., McElderry H. T., Plumb V. J., Epstein A. E. Limited response to cardiac resynchronization therapy in patients with concomitant right ventricular dysfunction. J. Cardiovasc. Electrophysiol. 2010; 21(4): 431–435.; Лишманов Ю. Б., Завадовский К. В., Ефимова И. Ю., Кривоногов Н. Г., Ефимова И. Ю., Веснина Ж. В., Сазонова С. И., Саушкина Ю. В., Саушкин В. В., Ильюшенкова Ю. Н., Гуля М. О., Пешкин Я. А., Мочула А. В. возможности ядерной медицины в диагностике сердечно-сосудистых заболеваний. Сибирский медицинский журнал. 2015; 30(2): 21–29.; Завадовский К. В., Панькова А. Н. сцинтиграфическая оценка дисфункции правого желудочка сердца у пациентов с тромбоэмболией легочной артерии. Медицинская визуализация. 2009; 3: 24–30.; Лебедев Д. И., Криволапов С. Н., Завадовский К. В., Сазонова С. И., Карпов Р. С., Попов С. В. Состояние сократительной функции миокарда правого желудочка, как предиктор эффективности проводимой сердечной ресинхронизирующей терапии. Российский кардиологический журнал. 2017; 7(147): 87–92.; Лебедев Д. И., Попов С. В., Мишкина А. И., Лебедева М. В. Влияние сократительной функции миокарда правого желудочка на эффективность проводимой сердечной ресинхронизирующей терапии. Кардиология. 2018; 58(S2): 19–24. DOI:10.18087/cardio.2436.; Zavadovsky K. V., Gulya M. O., Lishmanov Yu. B., Lebedev D. I. Perfusion and metabolic scintigraphy with 123i-bmipp in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy. Ann. Nucl. Medicine. 2016; 30(5): 325–333.; Wakabayashi T., Nakata T., Hashimoto A., Yuda S., Tsuchihashi K., Travin M. I., Shimamoto K. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J. Nucl. Med. 2001; 42(12): 1757–1767.; Gerson M. C., McGuire N., Wagoner L. E. Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy. J. Card. Fail. 2003; 9: 384–391.; https://www.sibjcem.ru/jour/article/view/449

  4. 4
    Academic Journal

    Πηγή: Complex Issues of Cardiovascular Diseases; № 1 (2015); 5-9 ; Комплексные проблемы сердечно-сосудистых заболеваний; № 1 (2015); 5-9 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2015-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/109/111; Мамедов М . Н., Чепурина Н. А . Суммарный сердечно-сосудистый риск: от теории до практики. М.: Д-р Редди’с; 2008. Mamedov M. N., Chepurina N. A. Summarnyi serdechnososudistyi risk: ot teorii do praktiki. Moscow: D-r Reddi’s; 2008. [In Russ].; Berman D. S., Hachamovitch R., Shaw L. J., Friedman J. D., Hayes S. W., Thomson L. E. J. et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease. J. Nucl. Med. 2006 Jan; 47 (1): 74–82.; Mahmarian J. J. Combining myocardial perfusion imaging with computed tomography for diagnosis of coronary artery disease. Curr. Opin. Cardiol. 2007 Sep; 22 (5): 413–421.; Agatston A. S., Janowitz W. R., Hildner F. J., Zusmer N. R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 1990; 15 (4): 827–832. doi:10.1016/0735-1097(90)90282-T.; Budoff M. J., Achenbach S., Blumenthal R. S., Carr J. J., Goldin J. G., Greenland P. et al. Assessment of Coronary Artery Disease by Cardiac Computed Tomography : A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation, 2006; 114: 1761–1791.; Терновой С. К ., Синицын В . Е ., Гагарина Н. В . Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий. М.: Атмосфера; 2003. Ternovoi S. K., Sinitsyn V. E., Gagarina N. V. Neinvazivnaya diagnostika ateroskleroza i kal’tsinoza koronarnykh arterii. Moscow: Atmosfera; 2003. [In Russ].; Архипова И . М ., Мершина Е . А ., Синицын В . Е . Роль КТ-коронарографии в диагностике ИБС на амбулаторном этапе. Поликлиника. Спецвыпуск Лучевая диагностика. 2013; 3: 18–21. Arkhipova I. M., Mershina E. A., Sinitsyn V. E. Rol’ KTkoronarografii v diagnostike IBS na ambulatornom etape. Poliklinika. Spetsvypusk. Luchevaya diagnostika. 2013; 3: 18–21. [In Russ].; Gaemperli O., Bengel F. M., Kaufmann P. A. Cardiac hybrid imaging. European Heart Journal, 2011; 32: 2100–2108.; Де Фейтер П. Д., Ахенбах Ш., Ньюман К . Клиническое применение компьютерной томографии сердца. Болезни сердца и сосудов: Руководство Европейского общества кардиологов: пер. с англ. под ред. А. Д. Кэмма, Т. Ф. Люшера, П. В. Серруиса. М.: ГЭОТАР-МЕДИА; 2011. С. 188–204. De Feyter P. J., Achenbach S., Nieman K. Cardiovascular Computed Tomography. The ESC Textbook of Cardiovascular Medicine. SECOND EDITION. doi:10.1093/med/ 9780199566990.003.006.; Федоров В . Д., Кармазановский Г . Г ., Коков Л . С., Коростелев А . Н., Несук О . М ., Тарбаева Н. В . Клиническое значение мультиспиральной компьютерно-томографической коронарографии. Хирургия. Журнал им. Н. И. Пирогова. 2010; 7: 4–9. Fedorov V. D., Karmazanovskii G. G., Kokov L. S., Korostelev A. N., Nesuk O. M., Tarbaeva N. V. The role of multispiral computed tomographic coronarography. Khirurgiya. Zhurnal imeni N. I. Pirogova (Surgery). 2010; 7: 4–9. [In Russ].; Mahnken A. H. CT Imaging of Coronary Stents: Past, Present, and Future. Cardiology 2012; 1: 1–12.; Dillman J. Role of CT in the evaluation of congenital cardiovascular disease in children. Am. J. Roentg. 2009; 192: 1219–1231.; Clark A. N., Beller G. A. The present role of nuclear cardiology in clinical practice. J. Nucl. Med. Mol. Imaging. 2005; 49 (1): 43–58.; Marcassa C., Bax J. J., Bengel F., Hesse B., Petersen C. L., Reyes E. et al. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur. Heart J. 2008 Feb; 29 (4): 557–563. doi:http:// dx.doi.org/10.1093/eurheartj/ehm607.; Лишманов Ю. Б., Чернов В . И . Сцинтиграфия миокарда в ядерной кардиологии. Томск: Изд-во Том. ун-та; 1997. 276 с. Lishmanov Yu. B., Chernov V. I. Stsintigrafiya miokarda v yadernoi kardiologii. Tomsk: Izd-vo Tom. un-ta; 1997. [In Russ].; De Jong M. C., Genders T. S. S., Van Geuns R-J., Moelker A., Hunink M. G. M. Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. Eur. Radiol. 2012; 22 (9): 1881–1895.; Voudris V., Avramides D., Koutelou M., Malakos J., Manginas A., Papadakis M. et al. Relative coronary flow velocity reserve improves correlation with stress myocardial perfusion imaging in assessment of coronary artery stenosis. Chest. 2003; 124 (4): 1266–1274. doi:10.1378/chest.124.4.1266.; Klocke F. J., Baird M. J., Bateman T. M., Berman D. S., Carabello B. A., Cerqueira M. D. et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging – executive summary: a report of the American College of Cardiology. American Heart Association Task Force on Practice Guidelines. 2003; American College of Cardiology. Available from: http://www.acc.org/clinical/guidelines/radio/ index.pdf.; Shaw L. J., Iskandrian A. E. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004; 11: 171– 185.; Beyer T., Townsend D. W., Blodgett T. M. Dualmodality PET/CT tomography for clinical oncology. J. Nucl. Med. 2002; 46 (1): 24–34.; Schillaci O. Hybrid SPECT/CT: a new era for SPECT imaging? Eur J Nucl Med Mol Imaging. 2005; 32 (5): 521– 524.; Gaemperli O., Schepis T., Kalff V., Namdar M., Valenta I., Stefani L. et al. Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur. J. Nucl. Med. Mol. Imaging. 2007; 34 (7): 1097–1106.; Namdar M., Hany T. F., Koepfli P., Siegrist P. T., Burger C., Wyss C. A. et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J. Nucl. Med. 2005; 46: 930–935.; Rispler S., Keidar Z., Ghersin E., Roguin A., Soil A., Dragu R. et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J. Am. Coll. Cardiol. 2007; 49: 1059–1067.; Sato A., Nozato T., Hikita H., Miyazaki S., Takahashi Y., Kuwahara T. et al. Incremental value of combining 64-slice computed tomography angiography with stress nuclear myocardial perfusion imaging to improve noninvasive detection of coronary artery disease. J. Nucl. Cardiol. 2010; 17: 19–26.; Van Werkhoven J. M., Schuijf J. D., Gaemperli O., Jukema J. W., Boersma E., Wijns W. et al. Prognostic value of multi-slice computed tomography and gated single photon emission computed tomography in patients with suspected coronary artery disease. J. Am. Coll. Cardiol. 2009; 53: 623–632.; Gaemperli O., Saraste A., Knuuti J. Cardiac hybrid imagine. Eur. Heart J. Cardiovasc. Imaging. 2012; 13 (1): 51–60.; Hsu H.-B., Shiau Y.-C., Kao A., Lin C. C., Lee C. C. Technetium-99m tetrofosmin myocardial perfusion single photon emission computed tomography in syndrome X: a preliminary report. Jpn. Heart J. 2003; 44 (2): 153–162.

  5. 5
    Academic Journal

    Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 16, № 2 (2014); 52-59 ; Вестник трансплантологии и искусственных органов; Том 16, № 2 (2014); 52-59 ; 1995-1191 ; 10.15825/1995-1191-2014-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/202/144; Rav al Z. et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011; 58 (3): 223–231.; Fath ala A., Safar B., Muhaideb A.Al. Prevalence of myocardial perfusion abnormalities in end-stage liver disease. Indian J Nucl Med. 2011; 26 (1): 7–10.; Ali A . et al. Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management. Clin Transplant. 2013; 27 (3): E207–215.; Oprea- Lager D.E. et al. Clinical value of myocardial perfusion scintigraphy as a screening tool in liver transplant candidates. Liver Transpl. 2011; 17 (3): 261–269.; Murray K.F., Carithers R.L.Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005; 41 (6): 1407–1432.; Moller S ., Henriksen J.H. Cirrhotic cardiomyopathy. J Hepatol. 2010; 53 (1): 179–190.; Alqahtani S.A., Fouad T.R., Lee S.S. Cirrhotic cardiomyopathy. Semin Liver Dis. 2008; 28 (1): 59–69.; Nagueh S.F . et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22 (2): 107–133.; Harinstein M.E. et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant. 2008; 8 (7): 1523–1528.; Aydinalp A. et al. Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates. Transplant Proc. 2009; 41 (9): 3757–3760.; Yilmaz Y. et al. Coronary fl ow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fi brosis. Atherosclerosis. 2010; 211 (1): 182–186.; Park S.C. et al. Echocardiographic fi ndings before and after liver transplantation. Am J Cardiol. 1985; 55 (11): 1373–1378.; Soresi M. et a l. Hemodynamic changes in splanchnic circulation after orthotopic liver transplantation in patients with liver cirrhosis. Abdom Imaging. 2002; 27 (5): 541–545.; Shi X.Y. et al. Cardiac arrest after graft reperfusion during liver transplantation. Hepatobiliary Pancreat Dis Int. 2006; 5 (2): 185–189.; De Marco M. et a l. Increased left ventricular mass in preliver transplantation cirrhotic patients. J Cardiovasc Med (Hagerstown). 2008; 9 (2): 142–146.; Stewart K.S. et a l. Nonischemic cardiomyopathy after orthotopic liver transplantation: a report of three cases and a review of the literature. Liver Transpl. 2005; 11 (5): 573–578.; Cywinski J.B. et a l. Dynamic left ventricular outflow tract obstruction in an orthotopic liver transplant recipient. Liver Transpl. 2005; 11 (6): 692–695.; Lee A.R. et al. Dyn amic left ventricular outflow tract obstruction in living donor liver transplantation recipients – A report of two cases. Korean J Anesthesiol. 2010; 59 Suppl: S128–132.; Braunwald E. et al. T he Circulatory Response of Patients with Idiopathic Hypertrophic Subaortic Stenosis to Nitroglycerin and to the Valsalva Maneuver. Circulation. 1964; 29: 422–431.; Maraj S. et al. Induci bleleft ventricular outflow tract gradient during dobutamine stress echocardiography: an association with intraoperative hypotension but not a contraindication to liver transplantation. Echocardiography. 2004; 21 (8): 681–685.; Hennessey T. et al. Com bined heart and liver transplantation on cardiopulmonary bypass: report of four cases. Can J Anaesth. 2010; 57 (4): 355–360.; https://journal.transpl.ru/vtio/article/view/202

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15